Finance ❯Stock Market ❯S&P 500 ❯Market Performance

Investor Reactions

Johnson & Johnson Tops Q2 Estimates, Raises Full-Year Outlook

Robust oncology growth paired with medtech gains has underpinned J&J’s decision to lift its full-year guidance.

Federal Reserve Holds Rates Steady as U.S.-China Trade Talks Loom

Asian Markets Dip as Fed Warns of Inflation Risks from Trump's Policies